| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |